Read more in our editorial policy
Unlike tirzepatide, which activates both GLP-1 and GIP receptors, MariTide is a GIPR antagonist antibody/GLP-1R peptide agonist conjugate which means that it activates GLP-1 receptors while blocking GIP responses
Fatigue : Some patients experience temporary tiredness during the initial weeks, particularly with rapid dose escalation
addresses those concerns in a balanced, evidence-aware way
Contact your healthcare provider if you experience severe dehydration, symptoms of a urinary tract or genital infection that do not improve, dizziness, fainting, allergic reactions, or symptoms of diabetic ketoacidosis such as nausea, vomiting, abdominal pain, confusion, or difficulty breathing